Science-Backed GLP-1 medications, with active ingredient semaglutide, are FDA-approved for type 2 diabetes and have proven effective for weight loss
Alisia Chen , Karen Zhao , and Felicia Ceban screened and adjudicated abstracts, selected articles for full-text review, and extracted the data
Preventing Future Errors Reconstitution errors account for most peptide dosing mistakes
PhysOrg.com
The magnitude of the before and after difference is driven by baseline IGF-1, age, lifestyle support, and protocol consistency, not by the dose alone
With the right strategies in place, telehealth can support safe and effective GLP-1 therapy initiation